Extracellular Vesicles Derived from Lipopolysaccharide-Pretreated Periodontal Ligament Stem Cells Ameliorate Inflammatory Responses in Experimental Colitis via the PI3K/AKT Signaling Pathway
Shuai Tang,Wenyu Feng,Zekun Li,Xinjuan Liu,Tong Yang,Fulan Wei,Gang Ding
DOI: https://doi.org/10.2147/ijn.s494321
IF: 7.033
2024-11-27
International Journal of Nanomedicine
Abstract:Shuai Tang, 1– 4 Wenyu Feng, 2– 4 Zekun Li, 1 Xinjuan Liu, 1 Tong Yang, 1– 4 Fulan Wei, 2– 4 Gang Ding 1 1 School of Stomatology, Shandong Second Medical University, Weifang, Shandong, 261053, People's Republic of China; 2 Department of Orthodontics, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, People's Republic of China; 3 Shandong Key Laboratory of Oral Tissue Regeneration, Shandong University, Jinan, Shandong, 250012, People's Republic of China; 4 Shandong Provincial Clinical Research Center for Oral Diseases, Shandong University, Jinan, Shandong, 250012, People's Republic of China Correspondence: Gang Ding, School of Stomatology, Shandong Second Medical University, Baotong West Street No. 7166, Weifang, Shandong, 261053, People's Republic of China, Email Fulan Wei, Department of Orthodontics, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University, Wenhua West Road No. 44-1, Jinan, Shandong, 250012, People's Republic of China, Email Introduction: Inflammatory bowel disease is a complex chronic inflammatory condition characterized by dysbiosis of the gut microbiota and dysregulation of immune system. In recent years, extracellular vesicles (EVs) derived from mesenchymal stem cells have garnered significant attention for their beneficial potentials in immune modulation and tissue repair. This study aims to evaluate the therapeutic effects and underlying mechanisms of EVs derived from lipopolysaccharide (LPS)-pretreated periodontal ligament stem cells (PDLSCs) in mice with colitis. Methods: A mouse model of colitis was established using 3.0% dextran sulfate sodium (DSS). Following the induction of colitis, mice were treated via tail vein injection with either conventional PDLSC-derived EVs (P-EVs) or LPS-pretreated PDLSC-derived EVs (LPS pre-EVs). The EVs were characterized using transmission electron microscopy, nanoparticle tracking analysis, and Western blot analysis. The therapeutic effects and mechanisms were evaluated through a combination of small animal live imaging, disease activity index (DAI) scoring, histopathological staining, qRT-PCR, 16S rRNA gene sequencing, and mass spectrometry analysis. Results: The LPS pre-EVs exhibited typical EVs characteristics in terms of morphology, particle size distribution, and marker protein expression. Compared to P-EVs, LPS pre-EVs significantly ameliorated weight loss, DAI scores, colon length, and perianal symptoms in DSS-induced murine colitis. Additionally, LPS pre-EVs up-regulated the expression of Arginase-1, a typical M2 macrophage marker, and tight junction proteins, including ZO-1, Occludin, and Claudin-1, enhanced gut microbial diversity, and significantly regulated intestinal protein expression and activation of the PI3K/AKT signaling pathway. Conclusion: LPS pre-EVs exhibit significant anti-inflammatory and tissue repair effects in a mouse model of colitis. The underlying mechanisms may involve the regulation of macrophage polarization, maintenance of intestinal barrier function, modulation of the gut microbiota, and activation of the PI3K/AKT signaling pathway. Keywords: inflammatory bowel disease, periodontal ligament stem cells, extracellular vesicles, gut microbiota, PI3K/AKT signaling pathway Graphical Inflammatory bowel disease (IBD) is a chronic, recurrent, immune-mediated inflammatory condition of the intestine, primarily manifesting in two forms: Crohn's disease and ulcerative colitis, which often affect the ileum, rectum, and colon, leading to chronic inflammation and ulcer formation within the gastrointestinal tract. As a result, IBD patients experience symptoms such as weight loss, abdominal pain, diarrhea, and other gastrointestinal issues. 1,2 The pathogenesis of IBD remains unclear, but it is widely believed to involve multiple factors, including the immune responses, genetic predisposition, environmental influences, and the impact of gut microbiota on the body. 3,4 In patients with IBD, profound microenvironmental changes typically occur at the sites of intestinal mucosa. These changes include local nutrient depletion, an imbalance between oxygen supply and demand in the tissue, and the production of reactive nitrogen and oxygen intermediates. 5,6 The resulting oxidative stress, endoplasmic reticulum stress, and hypoxic stress signaling affect several key features, such as the integrity of the intestinal mucosal barrier, the survival of intestinal cells, immune regulation, and the diversity of the gut microbiota. 4 In the IBD microenvironment, cytokine-mediated interactions between imm -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology